KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $263,000 | -39.4% | 1,187,957 | -17.9% | 0.00% | – |
Q2 2022 | $434,000 | -81.3% | 1,446,714 | -14.1% | 0.00% | – |
Q1 2022 | $2,324,000 | -11.2% | 1,683,389 | -22.2% | 0.00% | – |
Q4 2021 | $2,617,000 | -55.9% | 2,162,374 | -4.6% | 0.00% | – |
Q3 2021 | $5,936,000 | -49.2% | 2,265,470 | +2.8% | 0.00% | – |
Q2 2021 | $11,680,000 | -17.3% | 2,204,009 | +5.2% | 0.00% | – |
Q1 2021 | $14,123,000 | +7.8% | 2,095,389 | +8.4% | 0.00% | – |
Q4 2020 | $13,105,000 | -17.9% | 1,932,850 | -9.1% | 0.00% | -100.0% |
Q3 2020 | $15,954,000 | -31.1% | 2,127,114 | -3.4% | 0.00% | 0.0% |
Q2 2020 | $23,155,000 | +32.0% | 2,203,116 | +10.4% | 0.00% | 0.0% |
Q1 2020 | $17,543,000 | +336.4% | 1,995,850 | +83.2% | 0.00% | – |
Q4 2019 | $4,020,000 | +2.0% | 1,089,403 | +5.2% | 0.00% | – |
Q3 2019 | $3,941,000 | -50.1% | 1,035,812 | -16.3% | 0.00% | – |
Q2 2019 | $7,896,000 | -3.5% | 1,237,683 | +25.1% | 0.00% | – |
Q1 2019 | $8,183,000 | +64.9% | 989,396 | -2.5% | 0.00% | – |
Q4 2018 | $4,962,000 | -1.5% | 1,014,836 | +98.9% | 0.00% | – |
Q3 2018 | $5,036,000 | -22.4% | 510,295 | +8.0% | 0.00% | – |
Q2 2018 | $6,488,000 | -3.8% | 472,557 | +10.9% | 0.00% | – |
Q1 2018 | $6,747,000 | +12.6% | 426,236 | +31.5% | 0.00% | – |
Q4 2017 | $5,992,000 | -17.6% | 324,051 | +1.8% | 0.00% | – |
Q3 2017 | $7,269,000 | – | 318,280 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |